Summary
Glutathione–doxorubicin (GSH–DXR) effectively induced apoptosis in rat hepatoma cells (AH66) at a lower concentration than DXR. After 24 h of drug treatment, DNA fragmentation of the cells was observed at the concentration of 1.0 μM DXR or 0.01 μM GSH–DXR. Increase in caspase-3 activity and DNA fragmentation were observed within 12 h and 15 h after treatment with either drug. Intracellular caspase-3 activity was increased in a dose-dependent manner after treatment with DXR or GSH–DXR, and caspase-3 activity correlated well with the ability to induce DNA fragmentation. When the cells were treated with either DXR or GSH–DXR for only 6 h, apoptotic DNA degradation and caspase-3 activation occurred 24 h after treatment. DNA fragmentation caused by these drugs was prevented completely by simultaneous treatment with the caspase-3 inhibitor, acetyl–Asp–Glu–Val–Asp-aldehyde (DEVD-CHO), at 10 μM. By contrast, DNA fragmentation was not prevented by the caspase-1 inhibitor, acetyl–Tyr–Val–Ala–Asp–aldehyde (YVAD-CHO), at the same concentration as DEVD-CHO, and caspase-1 was not activated at all by the treatment of AH66 cells with both DXR and GSH–DXR. These results demonstrate that DXR and GSH–DXR induce apoptotic DNA fragmentation via caspase-3 activation, but not via caspase-1 activation, and that GSH–DXR enhances the activation of caspase-3 approximately 100-fold more than DXR. Moreover, the findings suggested that an upstream apoptotic signal that can activate caspase-3 is induced within 6 h by treating AH66 cells with the drug.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Asakura, T., Takahashi, N., Takada, K., Inoue, T. & Ohkawa, K. (1997a). Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells. Anti-Cancer Drugs 8: 199–203.
Asakura, T., Ohkawa, K., Takahashi, N., Takada, K., Inoue, T. & Yokoyama, S. (1997b). Glutathione-doxorubicin conjugate expresses potent cytotoxicity by a suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells. Br J Cancer 76: 1333–1337.
Bose, R., Verheij, M., Haimovits-Friedman, A., Scotto, K., Fuks, Z. & Kolesnick, R. (1995). Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82: 405–414.
Chen, Z., Naito, M., Mashima, T. & Tsuruo, T. (1996). Activation of actin-cleavable interleukin 1-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res 56: 5224–5229.
Darmon, A. J., Nicholson, D. W. & Bleackley, R. C. (1995). Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377: 446–448.
Enari, M., Talanian, R. V., Wong, W. W. & Nagata, S. (1996). Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380: 723–726.
Evans, D. L. & Dive, C. (1993). Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res 53: 2133–2139.
Fernandes-Alnemri, T., Litwack, G. & Alnemri, E. S. (1994). CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 269: 30761–30764.
Herr, I., Wilhelm, D., Böhler, T., Angel, P. & Debatin, K-M (1997). Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J 16: 6200–6208.
Kaufmann, S. H. (1989). Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49: 5870–5878.
Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E. & Poirier, G. (1993). Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976–3985.
Kluck, R. M., Martin, S. J., Hoffman, B. M., Zhon, J. S., Green, D. R. & Newmeyer, D. D. (1997). Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J 16: 4639–4649.
Mizushima, N., Koike, R., Kohsaka, H., Kushi, Y., Handa, S., Yagita, H. & Miyasaka, N. (1996). Ceramide induces apoptosis via CPP32 activation. FEBS Lett 395: 267–271.
Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T-T, Yu, V. L. & Miller, D. K. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37–43.
Ohkawa, K., Hatano, T., Tsukada, Y. & Matsuda, M. (1993). Chemotherapeutic efficacy of the protein-doxorubicin conjugates on multidrug resistant rat hepatoma cell line in vitro. Br J Cancer 67: 274–278.
Takahashi, N., Asakura, T. & Ohkawa, K. (1996). Pharmacokinetic analysis of protein-conjugated doxorubicin (DXR) and its degraded adducts in DXR-sensitive and -resistant rat hepatoma cells. Anti cancer Drugs 7: 687–696.
Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kotsura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., Elliston, K. O., Ayala, J. M., Casano, F. J., Chin, J., Ding, GJ-F, Egger, L. A., Gaffney, E. P., Limjuco, G., Palyha, O. C., Raju, S. M., Rolando, A. M., Salley, J. P., Yamin, T-T, Lee, T. D., Shively, J. E., MacCross, M., Mumford, R. A., Schmidt, J. A. & Tocci, M. J. (1992). A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356: 768–772.
Voelkel-Johnson, C., English, A. J., Wold, W. S. M., Gooding, L. R. & Laster, S. M. (1995). Activation of intracellular proteases is an early event in TNF-induced apoptosis. J Immunol 154: 1707–1716.
Wang, L., Miura, M., Bergeron, L., Zhi, H. & Yuan, J. (1994). Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78: 739–750.
Wright, S. C., Wei, Q. S., Kinder, D. H. & Larrick, J. W. (1996). Biochemical pathways apoptosis: nicotinamide adenine dinucleotide-deficient cells are resistant to tumor necrosis factor or UV light activation of the 24-kD apoptotic protease and DNA fragmentation. J Exp Med 183: 463–471.
Yamashita, T., Naito, M., Kataoka, S., Kawai, H. & Tsuruo, T. (1995). Aspartate-based inhibitor of interleukin-1β-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells. Biochem Biophys Res Commun 209: 907–915.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Asakura, T., Sawai, T., Hashidume, Y. et al. Caspase-3 activation during apoptosis caused by glutathione–doxorubicin conjugate. Br J Cancer 80, 711–715 (1999). https://doi.org/10.1038/sj.bjc.6690414
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690414
Keywords
This article is cited by
-
Upregulation of apoptotic protease activating factor-1 expression correlates with anti-tumor effect of taxane drug
Medical Oncology (2021)
-
Conformational change in the active center region of GST P1-1, due to binding of a synthetic conjugate of DXR with GSH, enhanced JNK-mediated apoptosis
Apoptosis (2007)